The LSTM in the UK has opened a £20m ($23.2m) robotic AI laboratory to test drugs and vaccines against infections and diseases.
Novartis India’s board cleared the deal, after which the company signed an asset purchase agreement with Pfizer entities. Credit: JHVEPhoto / Shutterstock.com. Novartis India has agreed to pay ...
The identification of breeding Aedes aegypti in the UK follows the establishment of an invasive mosquito population in a region of Cyprus.
The EAHP and EFPIA want all individual doses to carry a barcode, an addition they say will further reduce medication errors.
Credit: Jo Panuwat D/Shutterstock.com Drug delivery specialist Aptar Pharma is collaborating with Aceso Therapeutics to advance development for the latter’s ACT-101 – an inhalable antisense ...
The FDA has granted accelerated approval to AstraZeneca's Etcamah (camizestrant), used with a CDK 4/6 inhibitor, for breast cancer.
The FDA has so far approved four botanical products, with a view to greenlight more. Credit: Svetliy/Shutterstock.com. The US Food and Drug Administration (FDA) is requesting public input on both the ...
Ionis claims Zanvastro will become available to US patients with rare neurodegenerative condition, Alexander disease “in the coming weeks”.
Superluminal’s MC4R agonist is being developed for rare genetic forms of obesity, including BBS and hypothalamic obesity. Credit: New Africa / Shutterstock.com. US-based biotechnology company ...
Dravet syndrome is described as a rare lifelong neurological disorder marked by frequent, often treatment-resistant seizures from infancy. Credit: one photo / Shutterstock.com. Médunik Canada has ...
At ESC 2026, a session presented by Dr Domenica Rubino covered the considerations to take into account when comparing oral and injectable formulations of GLP-1 therapies.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results